Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders i... (re Test Applications Nichols Institut...)

HOME >> MEDICINE >> TECHNOLOGY

Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders in Children

Date:8/30/2007

re Test Applications

Nichols Institute also is developing additional ClariSure tests to identify chromosome abnormalities associated with hematological malignancies, such as Leukemia. The ClariSure test is able to detect abnormalities even if cell division has yet to occur, which may enable it to detect abnormalities that suggest the presence of cancer in a higher percentage of patients than is possible using conventional cytogenetic and FISH techniques. The company expects to begin to provide ClariSure assays for hematological malignancies to hospital physicians, including oncologists and hematologists, by the end of this year.

About Mental Retardation

Mental retardation and developmental delay are characterized by significant limitations in intellectual functioning and impaired conceptual and social development. Causes of mental retardation range from chromosome abnormalities to pre-natal environmental conditions. Array CGH techniques will detect chromosome abnormalities in as many as five percent to 17 percent of individuals with mental retardation.(3) With an accurate diagnosis, children are more likely to receive counseling, education and other support appropriate for their condition.

About Quest Diagnostics

Quest Diagnostics is the leading provider of diagnostic testing, information and services that patients and doctors need to make better healthcare decisions. The company offers the broadest access to diagnostic testing services through its national network of laboratories and patient service centers, and provides interpretive consultation through its extensive medical and scientific staff. Quest Diagnostics is a pioneer in developing innovative new diagnostic tests and advanced healthcare information technology solutions that help improve patient care. Additional company information is available at http://www.questdiagnostics.com.

This communication contains cert
'/>"/>

SOURCE Quest Diagnostics
Copyright©2007 PR Newswire.
All rights reserved

3

GOOD

Page: 1 2 3 4
Related medicine technology :

1. MediQuest Concludes Confirmatory Phase III Study of Raynaud’s Therapy
2. Geron Corp. Licensee TA Sciences Announces Landmark 7/07/07 Teleconference to Answer Questions About TA-65, Their Telomerase Activator With Proven Age Management Benefits
3. To Stent or Not: Is That the Question?
4. Quest PharmaTechs Prostate Cancer Program Update
5. VioQuest Pharmaceuticals Announces Data Presentation for Its Akt Inhibitor VQD-002, at American Association for Cancer Research Annual Meeting
6. Afid Therapeutics Obtains Positive Evaluation of its Triple Mode Viral Sequestration Agents
7. New Advances in Gastric Diagnostics: Smaller is Better
8. West Nile Virus Screening and Diagnostics Technology Emerges In Step with North American Outbreak
9. Researchers Discover Method for Identifying How Cancer Evades the Immune System
10. Controlling the Spread of Healthcare Associated Methicillin Resistant Staphylococcus aureus Requires Active Surveillance
11. Genzyme Announces Data from First Phase 3 Study of Tolevamer in Patients with C. difficile Associated Diarrhea

Post Your Comments:

(Date:3/17/2010)... , March 17 Access MediQuip, LLC, the nation,s first and largest provider ... enhanced its proprietary Recall Management Service, "RMS," for its customers nationwide. The new release is ... while managing cost. , ... ...

(Date:3/17/2010)... CAMBRIDGE, Mass. , March 17 ... community for physicians, today announced the results of ... Therapies: Physicians Social Media Conversations. " The report ... blood clotting, anticoagulation, anti-platelet, and thrombolytic treatments. According ...

(Date:3/17/2010)... , March 17 Endo Pharmaceuticals (Nasdaq: ENDP ) today announced that it will present at the Barclays Capital 2010 Global Healthcare Conference ... products and development programs. , ... , , ... ...

Breaking Medicine Technology:Access MediQuip Announces Release of the Country's First Centralized Recall Management Service(SM) for Implantable Devices 2 Access MediQuip Announces Release of the Country's First Centralized Recall Management Service(SM) for Implantable Devices 3 Physicians Eagerly Await Xarelto but Generic Price Advantage Could be a Sticking Point 2 Physicians Eagerly Await Xarelto but Generic Price Advantage Could be a Sticking Point 3 Physicians Eagerly Await Xarelto but Generic Price Advantage Could be a Sticking Point 4 Endo to Present at Barclays Capital Global Healthcare Conference 2 Endo to Present at Barclays Capital Global Healthcare Conference 3 Adamari Lopez 26 Yoplait 28R 29 Committed to Continue Raising Awareness for Breast Cancer Risk Reduction Among the Hispanic Community 57192 1 Adamari Lopez 26 Yoplait 28R 29 Committed to Continue Raising Awareness for Breast Cancer Risk Reduction Among the Hispanic Community 57192 2 Adamari Lopez 26 Yoplait 28R 29 Committed to Continue Raising Awareness for Breast Cancer Risk Reduction Among the Hispanic Community 57192 3 Caraco Pharmaceutical Laboratories Ltd Announces Appointment of F Folsom Bell to Board of Directors 57189 1 Caraco Pharmaceutical Laboratories Ltd Announces Appointment of F Folsom Bell to Board of Directors 57189 2 Caraco Pharmaceutical Laboratories Ltd Announces Appointment of F Folsom Bell to Board of Directors 57189 3 Genomas Awarded 241 4 Million NIH SBIR Grant to Develop MRI+DNA Guided Biomarker System for Mental Illness 14058 1 Genomas Awarded 241 4 Million NIH SBIR Grant to Develop MRI+DNA Guided Biomarker System for Mental Illness 14058 2

[0] Access MediQuip Announces Release of the Country's First Centralized Recall Management Service(SM) for Implantable Devices [0] Physicians Eagerly Await Xarelto but Generic Price Advantage Could be a Sticking Point [0] Endo to Present at Barclays Capital Global Healthcare Conference

... of Disease on Work Status and,Productivity, WASHINGTON, May ... Disease Week(R) 2007 (DDW), from,long-term extensions of the ... that subjects with moderately to severely active,ulcerative colitis ... blinded phase of the trials maintained,improvement in their ...

... Bentley,Pharmaceuticals, Inc. (NYSE: BNT), a specialty pharmaceutical,company, ... sponsored by,the Company has been accepted for ... 67th Scientific Sessions in Chicago.,The abstract, entitled ... Study of Intranasal Insulin Spray,(Nasulin(TM)) and Injectable ...

Long-Term Extension of Ulcerative Colitis Study Shows Remicade,Responders Maintained Improvement Through Two Years of Follow-Up Bentley Late Breaking Abstract Accepted for Poster Presentation at,American Diabetes Association Scientific Sessions

(Date:3/21/2010)... 21, 2010 With stomach irritation preventing almost 2 ... today reported discovery of several substances that may be ... stomach pain in every cup. , Their report, ... American Chemical Society, included the counter-intuitive finding that espresso, ... on the tummy because these roasts contain a substance ...

(Date:3/21/2010)... WASHINGTON , March 21 Phyllis Schlafly , president and founder of the conservative grassroots public policy organization Eagle Forum, made the ... today in the House: , ... , , ... ... ...

(Date:3/21/2010)... NEW YORK , March 21 President Barack Obama ... health bill with promises that he will "fix" their fears of abortion funding ... Court made that clear in Youngstown Sheet & Tube Company v. Sawyer , ... ... ...

(Date:3/21/2010)... first time in humans, scientists used RNA to ... March 21 (HealthDay News) -- For the first ... gene-manipulation therapy to enter tumor cells and block ... cancer, researchers report. , "They,re basically putting ... don,t want this protein expressed for now," explained ...

(Date:3/18/2010)... ... events – it can actually take a toll on health, according to a new study ... ... impact the way people perceive negative events – it can actually take a toll on ...

Breaking Medicine News(10 mins):Health News:Brewing up a gentler java: Dark-roasted coffee contains stomach-friendly ingredient 2 Health News:Brewing up a gentler java: Dark-roasted coffee contains stomach-friendly ingredient 3 Health News:Schlafly: Health Care Vote Set to Expose the Myth of the 'Pro-Life Democrat' 2 Health News:Schlafly: Health Care Vote Set to Expose the Myth of the 'Pro-Life Democrat' 3 Health News:Betsy McCaughey Says Anti-Abortion Democrats Should not be Hoodwinked by President's Promise of Executive Order 'Fix' 2 Health News:Gene-Targeted Cancer Fix Could Be a Breakthrough 2 Health News:Gene-Targeted Cancer Fix Could Be a Breakthrough 3 Health News:Low Self-Esteem Can Threaten Health, Online Dating Study Finds 2 Health News:Low Self-Esteem Can Threaten Health, Online Dating Study Finds 3

[0] Brewing up a gentler java: Dark-roasted coffee contains stomach-friendly ingredient [0] Schlafly: Health Care Vote Set to Expose the Myth of the 'Pro-Life Democrat'[0] Betsy McCaughey Says Anti-Abortion Democrats Should not be Hoodwinked by President's Promise of Executive Order 'Fix'[0] Gene-Targeted Cancer Fix Could Be a Breakthrough [0] Low Self-Esteem Can Threaten Health, Online Dating Study Finds

... open their doors,Wednesday to Trick or Treaters and the ... Oct. 30 It,s not every day,pirates and gypsies ... witches and 3-foot tall bumblebees, and little goblins rarely,get ... more,than 150 nursing homes in California this Halloween, it,s ...

... LONDON, Oct. 30 Chiltern, a leading global ... Clinical,Trial Management Services, Inc. (CTMS) a Bristol, Tennessee ... States. From February,2008 the combined operation will be ... by Dr. Robert Vann, John Vann and Ben ...

... the worlds largest society for molecular imaging and nuclear ... Tuesdays Roll Call urging Congress to fund basic nuclear ... discoveries. Support DOE funding for nuclear medicine research, notes ... news of legislative and political interest to Capitol Hill ...

... face increasingly large-scale,health risks from our expanding impact ... extremes and dengue fever to obesity, diabetes and ... medical researchers have contributed to a new,report which ... increasing,risks to the health of Australians., Released today ...

... limiting bariatric surgeries to high-volume centers disproportionately restrict ... are among the most in need of them, ... researchers shows. , Government-imposed restrictions currently mandate a ... bariatric surgeries under Medicare and Medicaid because some ...

... Fiscal Year EPS Outlook for One-time Tax Benefit, ... (NYSE: PG ) announced net sales growth of ... segment delivered,mid-single digit or higher sales growth. Organic sales ... company,s four to six percent target,growth range. The Fabric ...

Halloween Events in Eureka, California Bring Young and Old Together for a Ghoulish Good Time Chiltern Announces Acquisition of an Independent USA Based Clinical Research Organization, Clinical Trial Management Services, Inc.SNM ad urges congress to fund nuclear medicine research Healthy planet, places and people at risk Government restrictions on weight loss surgeries limit access for poor, underinsured patients P&G Reports EPS of $0.92, Up 16% Behind 8% Sales Growth

... 30° Prism is designed ... and are recommended for ... BRVO etc.) and Rhegmatogenus ... be used for panretinal ...

The Chalam Mid Field lens can be used for air/gas exchange and has a bi-concave design to provide the widest field available in a direct image surgical lens. This lens was developed with K.V. Chalam,...

... somewhat higher magnification and increased stereopsis, the ... detailed visualization to the equatorial regions. The ... diabetics and in membrane peeling in proliferative ... Sterilizable Lenses The ACS Vitrectomy Lenses from ...

... visualization of virtually the entire retina including ... of the lens on the eye. It ... giant retinal tears, diagnosing and treating anterior ... retina in a vitreous cavity filled with ...

Medicine Products:

Direct Image 30 Prism Direct Image Mid Field SSV®Central Retinal (ACS)Mini Quad® (ACS)

Quest Diagnostics Introduces ClariSure(TM) Test for Identifying Chromosome Abnormalities Associated With 85 Developmental Disorders i...(re Test Applications Nichols Institut...),Health